[News Viscovery]
Vienna / Austria, April 2012 Data mining-specialist Viscovery Software GmbH continues to develop its data-mining business in the life science branch. In collaboration with mother company Biomax Informatics AG, Viscovery is contributing to the establishment of a new data center for CIRO+ in the Netherlands by providing data mining software and consulting. This is the first integrated patient-centric knowledge management system for patient stratification and targeted therapy in chronic obstructive pulmonary disease (COPD).
"The CIRO+ Data Center allows, for the first time, to better understand patient outcome based on systematic pre- and post-assessment data of more than 3,000 patients over the past 6 years with up to 6,000 clinical data points captured for each patient. The impact of being able to exploit clinical knowledge effectively using state-of-the-art technology cannot be overestimated. This applies to both improved patient care and better management of treatment costs”, as Prof. Wouters, Chairman Board of Directors CIRO+, explained at the announcement of the CIRO+ Data Center launch.
In addition to this project, the Viscovery data-mining approach using SOM methodology is supporting medical research with identification of possible candidates for biomarkers by allowing clinical data to be examined and clustered with genetic data. Recently, projects in drug efficacy as well as the classification of clinical data to distinguish responsive and unresponsive patients have been successfully completed.
The international Cancermotisys research project (biomax.com/project/cancermotisys), examining the specific effects of stomach cancer drugs, is in its third year and close to completion. Viscovery has been involved in examining the relationship between cancer cell motility and genetic expression data.